Thomas P Soloway - Net Worth and Insider Trading
Thomas P Soloway Net Worth
The estimated net worth of Thomas P Soloway is at least $3,871 dollars as of 2024-12-27. Thomas P Soloway is the SVP, Operations and CFO of Paratek Pharmaceuticals Inc and owns about 1,736 shares of Paratek Pharmaceuticals Inc (PRTK) stock worth over $3,871. Details can be seen in Thomas P Soloway's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas P Soloway has not made any transactions after 2011-12-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas P Soloway
Thomas P Soloway Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas P Soloway owns 4 companies in total, including Satsuma Pharmaceuticals Inc (STSA) , Audentes Therapeutics Inc (BOLD) , and Paratek Pharmaceuticals Inc (PRTK) among others .
Click here to see the complete history of Thomas P Soloway’s form 4 insider trades.
Insider Ownership Summary of Thomas P Soloway
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| STSA | Satsuma Pharmaceuticals Inc | 2023-06-08 | director |
| BOLD | Audentes Therapeutics Inc | 2020-01-15 | Executive Vice President & CFO |
| PRTK | Paratek Pharmaceuticals Inc | 2011-12-01 | SVP & Operations and CFO |
 | | 2022-09-14 | director |
Thomas P Soloway Latest Holdings Summary
Thomas P Soloway currently owns a total of 1 stock. Thomas P Soloway owns 1,736 shares of Paratek Pharmaceuticals Inc (PRTK) as of December 1, 2011, with a value of $3,871.
Latest Holdings of Thomas P Soloway
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRTK | Paratek Pharmaceuticals Inc | 2011-12-01 | 1,736 | 2.23 | 3,871 |
Holding Weightings of Thomas P Soloway
Thomas P Soloway Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas P Soloway has made a total of 0 transactions in Paratek Pharmaceuticals Inc (PRTK) over the past 5 years. The most-recent trade in Paratek Pharmaceuticals Inc is the sale of 5,222 shares on December 1, 2011, which brought Thomas P Soloway around $528,308.
Insider Trading History of Thomas P Soloway
- 1
Thomas P Soloway Trading Performance
Thomas P Soloway Ownership Network
Thomas P Soloway Owned Company Details
What does Satsuma Pharmaceuticals Inc do?
Who are the key executives at Satsuma Pharmaceuticals Inc?
Thomas P Soloway is the director of Satsuma Pharmaceuticals Inc. Other key executives at Satsuma Pharmaceuticals Inc include 10 percent owner Shin Nippon Biomedical Laboratories, Ltd. , director & 10 percent owner Ken Takanashi , and 10 percent owner Braden Michael Leonard .
Satsuma Pharmaceuticals Inc (STSA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Satsuma Pharmaceuticals Inc (STSA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Satsuma Pharmaceuticals Inc (STSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Satsuma Pharmaceuticals Inc (STSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Satsuma Pharmaceuticals Inc Insider Transactions
Thomas P Soloway Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas P Soloway. You might contact Thomas P Soloway via mailing address: C/o Audentes Therapeutics, Inc., 600 California St., 17th Floor, San Francisco Ca 94108.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
